IFITM proteins - cellular inhibitors of viral entry

被引：101

作者：

Smith, S. E. ^{[1
]}

Weston, S. ^{[2
]}

Kellam, P. ^{[1
,3
]}

Marsh, M. ^{[2
]}

机构：

[1] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England

[2] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England

[3] UCL, Div Infect & Immun, MRC UCL Ctr Med Mol Virol, London WC1E 6BT, England

来源：

CURRENT OPINION IN VIROLOGY | 2014年 / 4卷

基金：

英国生物技术与生命科学研究理事会; 英国医学研究理事会; 英国惠康基金;

关键词：

INDUCED TRANSMEMBRANE PROTEIN-3; ANTIVIRAL ACTIVITY; S-PALMITOYLATION; HIV-1; INFECTION; VIRUS; RESTRICTS; GENE; RESISTANCE; TETHERIN; FAMILY;

D O I：

10.1016/j.coviro.2013.11.004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Interferon inducible transmembrane (IFITM) proteins are a recently discovered family of cellular anti-viral proteins that restrict the replication of a number of enveloped and non-enveloped viruses. IFITM proteins are located in the plasma membrane and endosomal membranes, the main portals of entry for many viruses. Biochemical and membrane fusion studies suggest IFITM proteins have the ability to inhibit viral entry, possibly by modulating the fluidity of cellular membranes. Here we discuss the IFITM proteins, recent work on their mode of action, and future directions for research.

引用

页码：71 / 77

页数：7

共 50 条

[21] Entry Inhibitors: Efficient Means to Block Viral Infection
Pattnaik, Gourab Prasad
Chakraborty, Hirak
JOURNAL OF MEMBRANE BIOLOGY, 2020, 253 (05) : 425 - 444
[22] Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity
Meischel, Tina
Fritzlar, Svenja
Villalon-Letelier, Fernando
Smith, Jeffrey M.
Brooks, Andrew G.
Reading, Patrick C.
Londrigan, Sarah L.
PATHOGENS, 2023, 12 (04):
[23] IFITM3 inhibits severe fever with thrombocytopenia syndrome virus entry and interacts with viral Gc protein
Du, Shouwen
Wang, Yuhang
Wang, Jiamin
Ma, Yidan
Xu, Wang
Shi, Xiaoshuang
Li, Letian
Hao, Pengfei
Liu, Quan
Liao, Ming
Zhou, Boping
Jin, Ningyi
Wong, Yin K.
Hu, Lifen
Wang, Jigang
Liu, Wei
Li, Chang
JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (03)
[24] Neutralizing antibodies to block viral entry and for identification of entry inhibitors
Tam, Ee Hong
Peng, Yu
Cheah, Megan Xin Yan
Yan, Chuan
Xiao, Tianshu
ANTIVIRAL RESEARCH, 2024, 224
[25] IFITM proteins inhibit HIV-1 protein synthesis
Lee, Wing-Yiu Jason
Fu, Rebecca Menhua
Liang, Chen
Sloan, Richard D.
SCIENTIFIC REPORTS, 2018, 8
[26] Cellular and viral determinants of retroviral nuclear entry
Bin Hamid, Faysal
Kim, Jinsun
Shin, Cha-Gyun
CANADIAN JOURNAL OF MICROBIOLOGY, 2016, 62 (01) : 1 - 15
[27] HIV-resistance to viral entry inhibitors
Menéndez-Arias, L
Esté, JA
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (15) : 1845 - 1860
[28] Antiviral Role of IFITM Proteins in Classical Swine Fever Virus Infection
Li, Cheng
Zheng, Hongqing
Wang, Yifan
Dong, Wang
Liu, Yaru
Zhang, Liang
Zhang, Yanming
VIRUSES-BASEL, 2019, 11 (02):
[29] IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise
Buchrieser, Julian
Degrelle, Severine A.
Couderc, Therese
Nevers, Quentin
Disson, Olivier
Manet, Caroline
Donahue, Daniel A.
Porrot, Francoise
Hillion, Kenzo-Hugo
Perthame, Emeline
Arroyo, Marlene V.
Souquere, Sylvie
Ruigrok, Katinka
Dupressoir, Anne
Heidmann, Thierry
Montagutelli, Xavier
Fournier, Thierry
Lecuit, Marc
Schwartz, Olivier
SCIENCE, 2019, 365 (6449) : 176 - +
[30] Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir
Gaisina, Irina N.
Peet, Norton P.
Cheng, Han
Li, Ping
Du, Ruikun
Cui, Qinghua
Furlong, Kevin
Manicassamy, Balaji
Caffrey, Michael
Thatcher, Gregory R. J.
Rong, Lijun
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (06) : 3120 - 3130

← 1 2 3 4 5 →